FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO
ALA: Lung Cancer Survival Has Increased Nationally to 22.6 Percent
People of color face worse outcomes, have lower likelihood of being diagnosed early, receiving surgery
High-Dose Anticoagulation May Not Aid COVID-19 Patients
No significant benefit seen for high-dose versus standard anticoagulation therapies, may be harmful
Physician’s Briefing Weekly Coronavirus Roundup
CDC: About One in Five U.S. Adults Reports Tobacco Product Use
Prevalence of any current tobacco product use up for men; adults aged ≤65 years; lesbian, gay, bisexual adults
Less Than One in 20 Eligible Adults Receives Lung Cancer Screening
Lung cancer screening at the state level does not correlate with lung cancer burden
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
U.S. COVID-19 Deaths Top a Quarter Million
COVID-19 cases on the rise in all but one state
Predictors of Severe Disease ID’d in Children With SARS-CoV-2
Obesity and hypoxia on admission predictive of severe respiratory disease; children with MIS-C more likely to be non-Hispanic Black
Wrong-Patient Order Entry Errors Reduced With Patient Photos
Display of patient photographs in electronic health records associated with decrease in WPOE errors
